Form 4: Beyond Air Director Carey Acquires Shares and Warrants in Private Placement and Loan Agreement

Robert Carey, a director of Beyond Air, Inc., acquired common stock and warrants through a private placement and a loan agreement, as detailed in a Form 4 filing with the SEC.

Summary

• On September 26 and 27, 2024, Robert Carey, a director of Beyond Air, Inc., engaged in transactions involving the company's securities.
• Carey acquired 1,476,626 shares of common stock at $0.5043 per share through a private placement.
• He also acquired pre-funded warrants to purchase 506,321 shares at an exercise price of $0.0001 per share and common warrants to purchase 1,982,947 shares at an exercise price of $0.3793 per share, also as part of the private placement.
• These warrants are exercisable after stockholder approval is obtained.
• Additionally, on September 27, 2024, Carey acquired warrants to purchase up to 9,886,633 shares of common stock in connection with a $7,500,000 loan to Beyond Air, Inc.
• These warrants will also be exercisable after the Initial Exercise Date and will expire five years following such date they are exercisable.
• The transactions were executed pursuant to a Securities Purchase Agreement and a binding term sheet.
• The reporting person acquired the securities through The Carey 2020 Acelyrin Trust DTD 07/23/2020, Robert F. Carey III Trust DTD 4/25/01 and BCR8V, LLC.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While a director increasing their stake is generally positive, the reliance on loans and the need for stockholder approval for warrant exercise introduce some uncertainty.

Positives

• A director's increased investment in the company may signal confidence in its future prospects.
• The $7,500,000 loan provides Beyond Air with additional capital.

Risks

• The exercise of warrants is contingent upon stockholder approval, which introduces uncertainty.
• The company's reliance on loans may indicate financial strain.

Future Outlook

The warrants are exercisable upon the company obtaining stockholder approval, which will impact the company's capital structure and potentially provide additional funding upon exercise.

Industry Context

Insider transactions are closely monitored as they can provide insights into management's perspective on the company's valuation and future prospects. A director increasing their stake could be seen as a positive signal.

Comparison to Industry Standards

• Comparing the terms of the warrants (exercise price and expiration) to similar biotech companies can provide context on whether the terms are favorable.
• Analyzing the loan agreement's interest rate and covenants against industry benchmarks can assess its impact on Beyond Air's financial flexibility.
• Similar private placements in the biotech industry can be used to benchmark the pricing and structure of this transaction.

Related Party Transactions

• The loan and warrant issuance to Robert Carey, a director, constitutes a related party transaction.

Stakeholder Impact

• Shareholders may experience dilution if the warrants are exercised.
• The loan provides the company with additional financial resources, potentially benefiting employees and other stakeholders.

Next Steps

• Beyond Air needs to obtain stockholder approval for the warrants to become exercisable.
• The company will need to manage the potential dilution from the exercise of these warrants.
• Monitor the company's cash flow and financial performance to assess the impact of the loan.

Key Dates